Apr 08, 2024 13:45 JST

Source: NEC Corporation

NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines

TOKYO, Apr 8, 2024 - (JCN Newswire) - NEC Corporation (TSE: 6701) has released a white paper, "Towards the realization of AI drug development: Comprehensive process workflow for the commercial use of personalized cancer vaccines". This white paper introduces (1) a comprehensive process workflow that can be applied to a wide range of processes, starting from tumor sample collection to vaccine design, manufacturing, supply, and administration, (2) important perspectives for consideration in the workflow, and (3) advanced technologies that will contribute to the realization of the workflow.

Click here for details and downloads (registration is not required)URL: www.nec.com/en/global/solutions/ai-drug/publication/index.html

NEC is committed to taking on the challenge of realizing new cancer treatments by aiming to establish an accurate, reliable, and comprehensive process workflow that utilizes AI and security technologies.

In recent years, there have been growing expectations for personalized neoantigen cancer vaccines as a next-generation cancer therapy. Personalized neoantigen cancer vaccines are a type of cancer immunotherapy that targets neoantigens containing genomic mutations that are specific to each patient. NEC is working on the realization of personalized cancer vaccines by using one of its core technologies, AI, to identify target neoantigens from each individual patient’s genome data.

This white paper proposes a comprehensive process workflow for personalized cancer vaccines, from design to administration, and the perspectives that should be discussed in this flow. Furthermore, NEC's advanced ICT technologies are introduced to address these perspectives, and the possibility that the use of ICT technology will contribute to the realization of a platform for not only personalized cancer vaccines, but also for various cancer treatments are discussed.

About NEC Corporation

NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com.

Source: NEC Corporation
Sectors: MedTech

Copyright ©2026 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Related Press Release


NEC Launches "Africa Corporate Innovation Program" Accelerating Business Through Co-Creation with African Startups
April 28 2026 18:05 JST
 
NEC Announces Strategic Collaboration with Anthropic Focused on Enterprise AI
April 23 2026 16:46 JST
 
NEC Receives Company of the Year recognition in Global Biometric Solutions from Frost & Sullivan
April 22 2026 13:46 JST
 
NEC to Supply Nine Types of Defense Equipment for Tthree Australian Frigates
April 19 2026 11:10 JST
 
IFS and NEC to Deploy Next-Generation Core System IFS Cloud for Hoshizaki
April 10 2026 09:10 JST
 
NEC's Automated Negotiation AI recognized as a Use Case in Gartner(R) Research
April 09 2026 12:41 JST
 
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
April 03 2026 11:33 JST
 
NEC Supports Ooredoo Algeria in Modernizing Enterprise Network Security with high-performance next-generation firewalls (NGFW)
March 31 2026 09:50 JST
 
Royal Healthcare in Singapore provides NEC's "FonesVisuas Test" for Disease Risk Prediction
March 26 2026 10:21 JST
 
Sumitomo Heavy Industries and NEC to develop system capable of identifying and reporting near-miss incidents
March 25 2026 13:27 JST
 
More Press release >>

Latest Press Release


More Latest Release >>